Skip to main content
    Z

    Zoetis Inc (ZTS)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NYSE

    $78.44
    +3.15 (+4.18%)

    Market Cap: $31.11B

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    90%(35/39)
    Avg Surprise
    +6.51%
    Streak
    1 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$1.51
    Range$1.46 - $1.60
    13 analysts
    EPS Revisions
    1
    0
    7d
    0
    13
    30d
    EPS Estimate DriftChange to current
    90d ago$1.85-18.0%
    60d ago$1.84-17.9%
    30d ago$1.51+0.4%
    7d ago$1.51+0.4%
    Current$1.51
    Revenue Consensus
    $2.3B
    Range$2.2B - $2.3B
    11 analysts
    Period ending Dec 31, 2026
    EPS Consensus$1.23
    Range$1.20 - $1.27
    14 analysts
    Revenue Consensus
    $2.1B
    Range$1.9B - $2.2B
    13 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$1.23---
    Sep 26EST
    		-$1.51---
    Jun 26
    Reported Aug 6
    		$1.87$1.84+1.63%Beat+6.3%
    Mar 26
    Reported May 7
    		$1.53$1.62-5.56%Miss+3.4%
    Dec 25
    Reported Feb 12
    		$1.48$1.40+5.71%Beat+5.7%
    Sep 25
    Reported Nov 4
    		$1.70$1.62+4.94%Beat+7.6%
    Jun 25
    Reported Aug 5
    		$1.76$1.61+9.32%Beat+12.8%
    Mar 25
    Reported May 6
    		$1.48$1.40+5.71%Beat+7.2%
    Dec 24
    Reported Feb 13
    		$1.40$1.36+2.94%Beat+12.9%
    Sep 24
    Reported Nov 4
    		$1.58$1.46+8.22%Beat+16.2%
    Jun 24
    Reported Aug 6
    		$1.56$1.48+5.41%Beat+10.6%
    Mar 24
    Reported May 2
    		$1.38$1.34+2.99%Beat+5.3%
    Dec 23
    Reported Feb 13
    		$1.24$1.32-6.06%Miss+7.8%
    Sep 23
    Reported Nov 2
    		$1.36$1.36+0.00%Beat+12.4%
    Jun 23
    Reported Aug 8
    		$1.41$1.31+7.63%Beat+17.5%
    Mar 23
    Reported May 4
    		$1.31$1.25+4.80%Beat-0.8%
    Dec 22
    Reported Feb 14
    		$1.15$1.15+0.00%Beat+15.0%
    Sep 22
    Reported Nov 3
    		$1.21$1.24-2.42%Miss-3.2%
    Jun 22
    Reported Aug 4
    		$1.20$1.22-1.64%Miss+0.8%
    Mar 22
    Reported May 5
    		$1.32$1.22+8.20%Beat+4.8%
    Dec 21
    Reported Feb 15
    		$1.00$0.96+4.17%Beat+9.9%
    Sep 21
    Reported Nov 4
    		$1.25$1.11+12.61%Beat+13.6%
    Jun 21
    Reported Aug 5
    		$1.19$1.09+9.17%Beat+33.7%
    Mar 21
    Reported May 6
    		$1.26$1.04+21.15%Beat+32.6%
    Dec 20
    Reported Feb 16
    		$0.91$0.87+4.60%Beat-1.1%
    Sep 20
    Reported Nov 5
    		$1.10$0.92+19.57%Beat+17.0%
    Jun 20
    Reported Aug 6
    		$0.89$0.65+36.92%Beat-1.1%
    Mar 20
    Reported May 6
    		$0.95$0.87+9.20%Beat+8.0%
    Dec 19
    Reported Feb 13
    		$0.92$0.88+4.55%Beat+16.5%
    Sep 19
    Reported Nov 7
    		$0.94$0.89+5.62%Beat+13.3%
    Jun 19
    Reported Aug 6
    		$0.90$0.82+9.76%Beat+16.9%
    Mar 19
    Reported May 2
    		$0.88$0.79+11.39%Beat+17.3%
    Dec 18
    Reported Feb 14
    		$0.79$0.77+2.60%Beat+14.5%
    Sep 18
    Reported Nov 1
    		$0.83$0.77+7.79%Beat+27.7%
    Jun 18
    Reported Aug 2
    		$0.77$0.70+10.00%Beat+45.3%
    Mar 18
    Reported May 2
    		$0.75$0.69+8.70%Beat+41.5%
    Dec 17
    Reported Feb 15
    		$0.69$0.66+4.55%Beat+46.8%
    Sep 17
    Reported Nov 2
    		$0.65$0.62+4.84%Beat-
    Jun 17
    Reported Aug 8
    		$0.53$0.53+0.00%Beat-
    Mar 17
    Reported May 4
    		$0.53$0.48+10.42%Beat-
    Dec 16
    Reported Feb 16
    		$0.47$0.45+4.44%Beat-

    Dividends

    Dividend Metrics

    Forward Yield2.70%
    Forward Annual Dividend$2.12
    Payout Ratio30.23%
    FrequencyQuarterly
    Pay MonthsMar, Jun, Sep, Dec

    Growth

    3Y CAGR+15.44%
    5Y CAGR+20.11%
    ZTS dividend history and ex-dividend datesRun ZTS in the free DRIP calculator

    Key Metrics

    Valuation
    P/E Ratio11.92EV/EBITDA10.10x
    Price/FCF13.84xFCF Yield7.22%
    Profitability
    Profit Margin27.70%Operating Margin40.70%
    ROE64.90%ROIC23.01%
    Financial Health
    Debt/Equity2.87xInterest Coverage14.75x
    Current Ratio3.08xQuick Ratio1.84x
    Trading Statistics
    Beta0.74Avg Volume4.39M
    52-Week High$145.5152-Week Low$68.77

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$73.56
    SMA 20$72.24
    SMA 50$73.94
    SMA 200$95.37
    EMA 10$74.31
    EMA 20$73.44
    EMA 50$74.28
    EMA 200$92.17

    MACD

    Line: 0.60Signal: -0.27Hist: 0.87

    ADX

    ADX: 20.9+DI: 32.8-DI: 12.4

    Aroon & PSAR

    Aroon Up100.0
    Aroon Down64.0
    PSAR$71.66

    Bollinger Bands

    Upper Band$76.99
    Lower Band$67.49
    %B Position1315%(Upper)
    Band Width1.15

    RSI (14-Day)

    Neutral
    67.4

    Momentum Oscillators

    Stoch %K86.7
    Stoch %D89.1
    Williams %R-6.8
    ROC (10d)13.5%
    Momentum9.34
    CCI (20d)226.0
    MFI (14d)63.8

    Volatility Measures

    ATR (14d)$1.98(2.5%)
    StdDev (20d)2.37
    Hist Vol28.1%(Moderate)

    Volume Flow

    VWAP$78.04
    OBV-91.5M
    AD Line-1.8B
    CMF (20d)-0.025

    Volume Metrics

    Avg Vol (20d)4.4M
    Vol Ratio1.1x
    VWMA (20d)$72.15

    Pivot Points

    R3$77.68
    R2$76.79
    R1$76.04
    Pivot Point$75.14
    S1$74.40
    S2$73.50
    S3$72.75

    Advanced Oscillators

    TSI8.43
    Ultimate Osc64.6
    KST-12.30

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$2.47B$2.26B$2.39B$2.40B$2.47B$2.20B$2.32B$2.39B$2.36B$2.19B$2.21B$2.15B
    Cost of Revenue$673.00M$641.00M$712.00M$683.00M$664.00M$618.00M$707.00M$701.00M$668.00M$643.00M$728.00M$638.00M
    Gross Profit$1.79B$1.62B$1.68B$1.72B$1.81B$1.58B$1.61B$1.69B$1.69B$1.55B$1.49B$1.51B
    Operating Expenses$873.00M$821.00M$866.00M$785.00M$843.00M$768.00M$847.00M$772.00M$829.00M$750.00M$784.00M$731.00M
    R&D$173.00M$180.00M$199.00M$170.00M$166.00M$162.00M$186.00M$167.00M$171.00M$162.00M$174.00M$152.00M
    SG&A$592.00M$588.00M$619.00M$579.00M$614.00M$574.00M$625.00M$565.00M$581.00M$547.00M$565.00M$525.00M
    Operating Income$922.00M$800.00M$809.00M$932.00M$967.00M$812.00M$763.00M$915.00M$864.00M$797.00M$701.00M$782.00M
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$61.00M$62.00M$57.00M$58.00M$53.00M$54.00M$51.00M$57.00M$59.00M$58.00M$59.00M$59.00M
    Income Before Tax$866.00M$758.00M$761.00M$887.00M$912.00M$773.00M$732.00M$874.00M$780.00M$747.00M$650.00M$717.00M
    Income Tax Expense$175.00M$157.00M$158.00M$166.00M$186.00M$171.00M$151.00M$182.00M$156.00M$148.00M$127.00M$121.00M
    Net Income$691.00M$601.00M$603.00M$721.00M$726.00M$602.00M$581.00M$692.00M$624.00M$599.00M$523.00M$596.00M
    EBITDA$1.05B$939.00M$939.00M$1.07B$1.09B$946.00M$906.00M$1.05B$966.00M$931.00M$835.00M$900.00M
    EBIT$927.00M$820.00M$818.00M$945.00M$965.00M$827.00M$783.00M$931.00M$839.00M$805.00M$709.00M$776.00M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    The Retirement Dividend Portfolio Everyone Wants Barely Exists

    Market has repriced safety - Republic Services 30.4x fwd, 1.13% yield; Badger Meter 28.3x, 1.17%; RTX 29x, 1.34%; most quality dividend names yield near 1-3% Nine-name scorecard shows eight yield under 3%, indicating the mid-yield...

    Leo Nelissen
    •
    9/3/26
    •
    292
    Dividend Investing, Dividend Growth, Portfolio Construction
    Also mentions:
    RSGTPLLBCSLCME

    Government Contracts

    Gov Obligations (TTM)
    $1.26M
    Gov Obligations / Revenue
    0.0%
    Obligations YoY
    N/A
    Active Awards
    9
    New Awards (TTM)
    6
    Avg Remaining Term
    7.7 mo

    Top agency: Department of Agriculture at 96.1% of trailing twelve month obligations across 4 agencies

    Recent Awards

    Award IDAgencyObligatedStart
    12639526F0420Department of AgricultureAnimal and Plant Health Inspection Service$626850May 1, 2026
    12639526P0058Department of AgricultureAnimal and Plant Health Inspection Service$484479May 7, 2026
    12639526P0106Department of AgricultureAnimal and Plant Health Inspection Service$99680Apr 10, 2026
    140FS226P0004Department of the InteriorU.S. Fish and Wildlife Service$35520Nov 20, 2025
    SPE2DS25P1684Department of DefenseDefense Logistics Agency$2182Aug 28, 2025
    SPE2DS26P1247Department of DefenseDefense Logistics Agency$382Mar 18, 2026

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    Q2 Earnings Outperformers: Elanco (NYSE:ELAN) And The Rest Of The Pharmaceuticals Stocks

    This article reviews the Q2 earnings performance of pharmaceutical stocks, highlighting Elanco (NYSE:ELAN) as an outperformer with significant revenue and EPS beats. It also examines Bristol-Myers Squibb (NYSE:BMY)...

    Yahoo Finance•10/14/26•Bearish

    Kabeer Aziz Acquires 2,465 Shares of AN2 Therapeutics at No Cost Under Director Compensation Plan

    Director Kabeer Aziz acquired 2,465 shares of AN2 Therapeutics, Inc. (NASDAQ:ANTX) common stock on October 12, 2026, at no cost...

    Kalkine Media•10/13/26•Neutral

    Why Did AllianceBernstein (NYSE:AB) Fall Despite Revenue Growth?

    AllianceBernstein (NYSE:AB) recently reached a new annual trading low despite reporting year-over-year revenue growth. This decline was attributed to a reduction in its stated share objective...

    Kalkine Media•10/13/26•Neutral

    Reducing Zoetis' Fair Value Estimate in Face of Rising Competition; Wide Moat Remains Intact

    Morningstar has reduced its fair value estimate for Zoetis due to increasing competitive pressures in the animal health industry. Despite the rising competition, the company maintains its "wide moat" rating...

    Morningstar•10/12/26•Somewhat-Bearish

    Zoetis: Reducing Our Valuation to Reflect Greater Competitive Pressure, but Moat Remains Intact

    Morningstar has reduced its valuation for Zoetis (ZTS) due to increased competitive pressure in 2026 and 2027. New product launches from Elanco and Merck are directly challenging Zoetis' key dermatology portfolio and its...

    Morningstar•10/12/26•Somewhat-Bearish

    ZTS Valuation and Fair Value

    P/E
    11.9x
    Forward P/E
    12.0x
    EV/EBITDA
    10.1x
    P/FCF
    13.8x
    PEG
    6.7x
    P/B
    10.4x
    See GNG's fair value

    ZTS Profitability: Margins, ROIC and FCF

    Gross margin
    71.5%
    Operating margin
    40.7%
    Net margin
    27.7%
    ROIC
    23.0%
    ROE
    64.9%
    FCF margin
    24.9%
    FCF yield
    7.2%

    ZTS Competitors

    CompanyTicker
    GE HealthCare Technologies Inc.GEHC
    West Pharmaceutical Services IncWST
    DexCom IncDXCM
    Laboratory Corporation of America HoldingsLH
    Mettler-Toledo International IncMTD
    Quest Diagnostics IncorporatedDGX
    ResMed IncRMD
    Roivant Sciences LtdROIV

    Sector: Healthcare

    ZTS Analyst Ratings

    Consensus
    Buy
    Analysts
    17
    Strong Buy
    4
    Buy
    4
    Hold
    9
    Sell
    0
    Strong Sell
    0

    ZTS Bull Case vs Bear Case

    Bull case

    • ZTS earns a 23.0% return on invested capital.
    • ZTS converts 24.9% of revenue into free cash flow.
    • ZTS has a 27.7% net profit margin.

    Bear case

    • ZTS's quarterly revenue changed -0.2% year over year.
    • ZTS has a debt-to-equity ratio of 2.9x.

    ZTS Earnings: Beat Rate and Next Report

    Beat rate
    7 of 8 quarters (87.5%)
    Average surprise
    4.1%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $1.51
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    0 up, 13 down

    ZTS Dividend

    Forward yield
    2.7%
    Payout ratio
    30.2%
    3Y DPS growth
    15.4%
    5Y DPS growth
    20.1%
    Pay months
    Mar, Jun, Sep, Dec
    ZTS dividend history

    Frequently Asked Questions About ZTS

    What is ZTS's current dividend yield?

    Zoetis Inc (ZTS) has a forward dividend yield of 2.70%.

    Does ZTS pay dividends?

    Yes, Zoetis Inc pays dividends with a forward dividend yield of 2.70%.

    What is ZTS's P/E ratio?

    Zoetis Inc has a price-to-earnings (P/E) ratio of 11.92.

    What is ZTS's market cap?

    Zoetis Inc (ZTS) has a market capitalization of $31.11B with a current stock price of $78.44.

    Related stocks

    Sector: Healthcare

    All stocks starting with Z

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In